What this study is
This innovative Multilevel Action Toward Colorectal Cancer (CRC) and Hepatitis C Virus (HCV) Education and Screening (MATCHES) intervention aims to promote concurrent HCV and CRC screening among FQHC patients ages 45-75.
What's being tested
- MATCHES
Intervention · BEHAVIORAL
Participants will be asked to complete a survey with specific topics including Hepatitis C (HCV) and Colorectal (CRC) knowledge and health beliefs, screening intentions and demographic characteristics. Participants will be provided with education intervention materials (for example, a booklet) either in-person or via mail, access to free stool-based CRC screening, and access to free HCV screening. Approximately 1-2 weeks after receiving the education materials, participants will be asked to complete a post-intervention survey about the same specific topics (for example, HCV and CRC knowledge, HCV and CRC health beliefs, HCV and CRC screening intentions, healthcare experiences, perceptions of the educational materials) over the phone with a trained study staff. Participants with a positive HCV screening and/or CRC screening result will be navigated to follow-up care as needed.
Study details
- Official title
- Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening (MATCHES)
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Conditions
- Colorectal Cancer Screening · Hepatitis C Virus
- Enrolling
- 350 people
- Starts
- 2024-10-21
- Est. completion
- 2028-04-30
- Design
- Open-label, single group
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 45 Years – 75 YearsSex ALLHealthy volunteers AcceptedYou may qualify if
- Participants must be receiving care at one of the participating FQHC clinics.
- Participants must be 45-75 years of age.
- Participants must not be up to date with Colorectal Cancer (CRC) screening recommendations such as no colonoscopy in the past 10 years, occult blood test in the past 12 months.
- Participants must never have had Hepatitis C Virus (HCV) antibody screening.
- Participants must be able to read, write, and understand English or Spanish.
- Participants must have no personal history of CRC or current presumptive CRC symptoms such as unresolved rectal bleeding or abdominal pain/bloating.
- Participants must be at average risk for CRC (no hereditary CRC syndromes such as lower gastrointestinal (GI) bleeding, persistent diarrhea, bloating, or lower GI pain, no strong family history of CRC).
- Participants must be asymptomatic for HCV.
- Participants receiving intervention materials must be able and willing to complete surveys and receive the patient level intervention.
- Participants completing qualitative interviews must be willing to complete a remote interview via phone or teleconference software such as ZOOM.
- Participants completing qualitative interviews must be willing to be audio recorded.
- Participants recruited for qualitative interviews only (did not receive MATCHES intervention materials) must have a clinic visit within prior two months.
- All Participants must be able to provide informed consent.
You can't join if
- Participants that do not meet all Inclusion Eligibility requirements will be excluded.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openMoffitt Cancer Center
Tampa, Florida, United States
- Carol Boxtha · Contact813-745-8963Carol.Boxtha@Moffitt.org
- Christy Shannon, PhD · Principal investigator
- Clement K Gwede, PhD, MPH, RN · Sub-investigator
- Susan T Vadaparampil, PhD · Sub-investigator
Recruiting
Study team
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Study ID MCC-23232
Principal investigator
Shannon Christy, PhD
Moffitt Cancer Center
Principal investigator
Clement K. Gwede, PhD, MPH, RN
Moffitt Cancer Center
CONTACT
Shannon Christy, PhD
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.